SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Inovio Pharmaceuticals Cytomegalovirus (CMV) Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study